OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism. Dai WQ, Xu L, Yu XN, Zhang GC, et al. J Hepatol 2019 Dec 30. pii: S0168-8278(19)30760.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dai WQ, Xu L, Yu XN, Zhang GC, et al. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism. J Hepatol 2019 Dec 30. pii: S0168-8278(19)30760.
PMID: 31899205